NCT07851844

Brief Summary

To describe the clinical, electrophysiological, and genetic characteristics of patients with genetic and inflammatory polyneuropathies in France.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
122mo left

Started Nov 2026

Longer than P75 for all trials

Geographic Reach
1 country

26 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 22, 2026

Completed
3 months until next milestone

First Posted

Study publicly available on registry

October 1, 2026

Completed
1 month until next milestone

Study Start

First participant enrolled

November 1, 2026

Expected
10 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2036

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2036

Last Updated

October 1, 2026

Status Verified

June 1, 2026

Enrollment Period

10 years

First QC Date

June 22, 2026

Last Update Submit

September 25, 2026

Conditions

Keywords

Rare DiseasesGenetic TestingElectrophysiologyChronic Inflammatory Demyelinating PolyradiculoneuropathyCharcot-Marie-Tooth DiseaseInflammatory NeuropathyHereditary NeuropathyPolyneuropathy

Outcome Measures

Primary Outcomes (1)

  • Number and percentage of participants by type of polyneuropathy

    Participants will be classified as having genetic or inflammatory polyneuropathy according to the diagnosis documented in their medical records. The number and percentage of participants in each category will be reported.

    At inclusion, based on the diagnosis documented in the medical record.

Secondary Outcomes (5)

  • Number and percentage of participants by polyneuropathy subtype

    At inclusion, based on the diagnosis documented in the medical record.

  • Demographic characteristics of patients

    At baseline, corresponding to the date of inclusion in the study, using data available in the medical record up to that date.

  • Geographical distribution of patients

    At baseline, corresponding to the date of inclusion in the study, using data available in the medical record up to that date.

  • Number and percentage of participants by electrophysiological neuropathy pattern

    At inclusion, based on electrophysiological examinations available in the medical record.

  • Genetic abnormalities

    At baseline, corresponding to the date of inclusion in the study, using genetic data available in the medical record up to that date.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adults diagnosed with genetic or inflammatory polyneuropathy and followed in participating neurology centers in France.

You may qualify if:

  • Adult patients aged 18 years or older.
  • Patients with a diagnosis of genetic or inflammatory polyneuropathy, confirmed by complementary examinations performed as part of routine care, including genetic, biological and/or electrophysiological tests.

You may not qualify if:

  • \- Patient opposition to the use of their routine care data for research purposes.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (26)

CHU Amiens-Picardie - Site Sud

Amiens, France

Location

CHU Angers

Angers, France

Location

Hôpital Pellegrin, CHU Bordeaux

Bordeaux, France

Location

Hôpital Morvan, CHU Brest

Brest, France

Location

Hôpital Pierre Wertheimer, HCL

Bron, France

Location

Hôpital Gabriel-Montpied, CHU Clermont-Ferrand

Clermont-Ferrand, France

Location

Hôpital François Mitterrand, CHU Dijon

Dijon, France

Location

Centre Hospitalier Annecy Genevois

Épagny, France

Location

Hôpital Raymond-Poincaré

Garches, France

Location

CHU Grenoble - Site Sud

Grenoble, France

Location

CHU de la Réunion - GH Sud Réunion - Saint-Pierre

La Réunion, France

Location

Hôpital Bicêtre

Le Kremlin-Bicêtre, France

Location

Hôpital Salengro, CHU de Lille

Lille, France

Location

Hôpital Dupuytren, CHU Limoges

Limoges, France

Location

Hôpital de la Timone, AP-HM

Marseille, France

Location

F-Esselin@Chu-Montpellier.Fr

Montpellier, France

Location

CHU Nantes - Hôtel-Dieu - Hôpital Mère-Enfant

Nantes, France

Location

Hôpital Pasteur, CHU Nice

Nice, France

Location

Hôpital Universitaire Carémeau, CHU Nîmes

Nîmes, France

Location

Hôpital Ambroise Paré

Paris, France

Location

Hôpital La Pitié-Salpetrière

Paris, France

Location

Hôpital Maison Blanche, CHU Reims

Reims, France

Location

Hôpital Charles-Nicolle, CHU Rouen

Rouen, France

Location

Hôpital de Hautepierre, Hôpitaux Universitaires de Strasbourg

Strasbourg, France

Location

Hôpital Rangueil, CHU Toulouse

Toulouse, France

Location

Hôpital Bretonneau CHRU de Tours

Tours, France

Location

MeSH Terms

Conditions

NeuritisRare DiseasesPolyradiculoneuropathy, Chronic Inflammatory DemyelinatingCharcot-Marie-Tooth DiseasePolyneuropathies

Condition Hierarchy (Ancestors)

Peripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsPolyradiculoneuropathyAutoimmune Diseases of the Nervous SystemDemyelinating DiseasesAutoimmune DiseasesImmune System DiseasesChronic DiseaseHereditary Sensory and Motor NeuropathyNervous System MalformationsHeredodegenerative Disorders, Nervous SystemNeurodegenerative DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesGenetic Diseases, Inborn

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 22, 2026

First Posted

October 1, 2026

Study Start (Estimated)

November 1, 2026

Primary Completion (Estimated)

November 1, 2036

Study Completion (Estimated)

November 1, 2036

Last Updated

October 1, 2026

Record last verified: 2026-06

Locations